Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
ETF Building Blocks ChannelBiotech ETF Doesn’t Need Coronavirus Vaccines to SoarBy Tom LydonJune 2, 2020
Disruptive Technology ChannelWhy ETF Investors Should Consider Allocating to InnovationBy Max ChenMay 14, 2020
Disruptive Technology ChannelMaking the Case for Innovation: Rethinking Traditional Asset AllocationBy Max ChenMay 13, 2020
Disruptive Technology ChannelETFs to Tap into Disruptive Technologies That Can Revolutionize the WorldBy Max ChenMarch 2, 2020
Disruptive Technology ChannelA Targeted Biotech ETF Is Brushing Off the SellingBy Max ChenFebruary 27, 2020
Disruptive Technology ChannelBiotech ETFs Are Not Riding the Wave from Coronavirus PanicBy Max ChenJanuary 24, 2020
Disruptive Technology ChannelTargeted ETFs to Hone in on Innovative Growth Ideas for 2020By Max ChenJanuary 23, 2020
Disruptive Technology ChannelActively Managed ETFs Provide Forward-Looking StrategiesBy Max ChenDecember 19, 2019
InvestingBiotech ETFs Slip as Trump Administration Pushes for Cheap Drug ImportsBy Max ChenDecember 18, 2019
Innovative ETFs ChannelBiotech ETFs Pop After Novartis Acquires Medicines Co.By Max ChenNovember 25, 2019
Disruptive Technology ChannelARK Invest ETFs Track Disruptive Companies Changing the WorldBy Max ChenNovember 18, 2019
WebcastsAn Active ETF Approach to Target Innovations in Next Generation SequencingBy Max ChenNovember 14, 2019
